SCHEMBL21030489

SCHEMBL21030489

CC(C)c1ccc(-n2cccn2)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
MAPT P10636 4/20 0.42
MEN1 O00255 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
G6PD P11413 1/20 0.42
NOTUM Q6P988 2/20 0.41
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
CHRM1 P11229 1/20 0.38
PTGS1 P23219 1/20 0.38
TDO2 P48775 1/20 0.37
ACLY P53396 1/20 0.35
BDKRB2 P30411 1/20 0.34
HTT P42858 1/20 0.34
MDM2 Q00987 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11495973 0.84 CRHR1 (0.37) POLBMAPTMEN1ALDH1A1KMT2A
SCHEMBL11485551 0.83 PTGS1 (0.60) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL22187765 0.81 MAPT (0.42) POLBMAPTMEN1ALDH1A1KMT2A
SCHEMBL21240912 0.79 USP9X (0.42) POLBMAPTMEN1ALDH1A1KMT2A
SCHEMBL9911399 0.79 KMT2A (0.46) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL11023550 0.78 NOTUM (0.56) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL30055522 0.78 NOTUM (0.56) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL11492673 0.78 CHRM1 (0.43) MAPTMEN1ALDH1A1KMT2ALMNA
SCHEMBL21031758 0.78 NOTUM (0.61) NOTUM
SCHEMBL12015799 0.78 KDM4E (0.39) POLBMAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO POLB 4814/4885MAPT 2864/4885MEN1 478/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO POLB 4814/4885MAPT 2864/4885MEN1 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.